In previous studies on the molecular genetic mechanisms of thyroid cancer, BRAF mutations were found to be the most frequently occurring mutations detected in 60-70% of papillary thyroid cancer (PTC) and 41-45% of anaplastic thyroid cancer (ATC) 1-3. The gene discussed is BRAF; the disease is thyroid cancer.